Quest Diagnostics Inc. closed 8.75% short of its 52-week high of $182.38, which the company achieved on June 16th.

Quest Diagnostics (DGX) is a strong buy with growth potential, solid margins, and dividend increases. Discover the full ...

The company plans to make the diagnostic available to physicians and researchers this summer, expanding its portfolio beyond ...

New York Giants rookies officially report for training camp on Tuesday, one week ahead of the remainder of the team.

While clinical laboratory Quest Diagnostics (DGX) had a rough outing last week, speculators seeking a discount may want to ...

Before the New York Giants reach training camp, Jaxson Dart was on vacation and showing off his arm strength in a new viral ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On June ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the testing & diagnostics ...

The Giants’ safety was a well-needed stabilizer for the back end of the defense in Year 1, and has yet to come close to hitting his ceiling.

With mid-July fast approaching, we're looking at what Eagles fans should know about the New York Giants before training camp ...

This was the stock's second consecutive day of losses.

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...